Research graph
References from Adverse outcomes in nontrial like patients on commercial HeartMate 3 LVAD support. Local targets link to admitted publications; unresolved targets remain external evidence.
Guidance for timely and appropriate referral of patients with advanced heart failure: a scientific statement from the American Heart Association
10.1161/cir.0000000000001016 · 2021 · External reference
2019 EACTS expert consensus on long-term mechanical circulatory support
10.1093/ejcts/ezz098 · 2019 · External reference
The long and winding road to an effective left ventricular assist device: the demise of Medtronic's HVAD
10.1161/circulationaha.121.056027 · 2021 · External reference
A fully magnetically levitated left ventricular assist device – final report
10.1056/nejmoa1900486 · 2019 · External reference
Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial
10.1001/jama.2022.16197 · 2022 · External reference
Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure
10.1371/journal.pone.0242928 · 2020 · External reference
Assessment of mortality among durable left ventricular assist device recipients ineligible for clinical trials
10.1001/jamanetworkopen.2020.32865 · 2021 · External reference
Generalizability of trial data to real-world practice: an analysis of the society of thoracic surgeons INTERMACS database
10.1016/j.athoracsur.2021.08.062 · 2022 · External reference
Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months
10.1161/circulationaha.117.028303 · 2017 · External reference
Left ventricular assist systems and infection-related outcomes: a comprehensive analysis of the MOMENTUM 3 trial
10.1016/j.healun.2020.03.002 · 2020 · External reference
Outcome of right ventricular assist device implantation following left ventricular assist device implantation: systematic review and meta-analysis
10.1177/02676591211024817 · 2022 · External reference
Trends and outcomes of left ventricular assist device therapy: JACC focus seminar
10.1016/j.jacc.2022.01.017 · 2022 · External reference
Unresolved reference
External reference
Prediction of survival after implantation of a fully magnetically levitated left ventricular assist device
10.1016/j.jchf.2022.08.002 · 2022 · External reference
Quality of life with an LVAD: a misunderstood concept
10.1016/j.hrtlng.2018.02.003 · 2018 · External reference
Risk assessment in patients with a left ventricular assist device across INTERMACS profiles using Bayesian analysis
10.1097/mat.0000000000000910 · 2019 · External reference
Outcomes after extracorporeal right ventricular assist device combined with durable left ventricular assist device support
10.1016/j.athoracsur.2018.11.051 · 2019 · External reference
Adverse events of temporary extracorporeal right ventricular assist devices placed with durable left ventricular assist devices
10.1016/j.healun.2022.01.1175 · 2022 · External reference
10.1001/jamacardio.2019.5323
10.1001/jamacardio.2019.5323 · 2020 · External reference
Left ventricular assist devices in advanced heart failure
10.1001/jama.2022.16348 · 2022 · External reference
Hospitalization patterns and impact of a magnetically-levitated left ventricular assist device in the MOMENTUM 3 trial
10.1016/j.jchf.2022.03.007 · 2022 · External reference
Time spent engaging in health care among patients with left ventricular assist devices
10.1016/j.jchf.2022.01.011 · 2022 · External reference
Thrivival: thriving and surviving for left ventricular assist device patients
10.1016/j.jchf.2022.02.009 · 2022 · External reference
Center variability in patient outcomes following HeartMate 3 implantation: an analysis of the MOMENTUM 3 trial
10.1016/j.cardfail.2022.04.006 · 2022 · External reference
